State Farm / Chevron U.S.A. Inc. / Serono Labs. / Novartis / Otsuka Pharmaceutical Development & Commercialization Inc. / Celotex Corp. / Bristol-Myers Squibb Co. / Overton Park Inc. / Actavis Elizabeth L.L.C. / USA Inc. / Otsuka American Pharmaceutical Inc. / Power & Light Co. / U.S. Inc. / Mylan Labs. / Purepac Pharm / Saint-Gobain Performance Plastics Corp. / TorPharm Inc. / Otsuka Pharmaceutical Co. Ltd. / Express Corp. / Cases aaiPharma Inc. / Mead Corp. / Teva / C & W Fish Co. / Hospira Inc. / /
Country
United States / /
Event
FDA Phase / Legal Issues / /
IndustryTerm
drug product / proposed drug product / generic product / Treatment of Irritability Associated with Autistic Disorder / Treatment of Bipolar I Disorder / generic applications / pharmaceutical / generic drug product / /
MedicalCondition
such disease / Major Depressive Disorder / rare diseases / Tourette’s Disorder / Schizophrenia / disease / I Disorder / rare disease / Autistic Disorder / Bipolar Disorder / /
MedicalTreatment
Adjunctive Therapy / /
Movie
D. III / D. IV / /
Organization
U.S. Department of Health and Human Services / United States Food and Drug Administration / Congress / US Federal Reserve / Thomas Jefferson Univ. / UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MARYLAND Otsuka Pharmaceutical Co. / FDA / Additional Authority / FDA’s Center for Drug Evaluation and Research / /
Person
Harris Cnty / Depressive Disorder / Sylvia Mathews Burwell / Thomas Jefferson / /
Position
Secretary / Major / /
Product
Abilify / Abilify Otsuka / ANDAs Although / such drug / ANDAs / New Drug / /
Case 8:15-cvGJH DocumentFiledPage 1 of 30 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MARYLAND Otsuka Pharmaceutical Co., Ltd., et al., Plaintiffs,